$CURR - Nice coverage for the company in this mont
Post# of 40256
(Total Views: 43)
Posted On: 05/04/2020 12:09:47 PM
Re: trooperstocks #13913
$CURR - Nice coverage for the company in this month's Pharma Manufacturing Journal
Link:
https://www.pharmamanufacturing.com/articles/...-delivery/
Product Focus: Advancements in drug delivery
New innovations enhance the patient experience
By Meagan Parrish, Senior Reporter
Apr 28, 2020
CURE 382 1
Oral solid dose may be the backbone of pharma, but recent innovations in drug delivery products are making it easier for patients and pharma companies to utilize alternatives.
“Tablets and gel capsules are compact and convenient for storage and transportation, yet many consumers have difficulty swallowing pills,” explains Bhaumik Patel, director of New Technology for CURE Pharmaceutical. “There are also limitations on the amount of active ingredients that can be delivered due to the size of these dose forms.”
Here’s a look at how innovations for injectables and chewables are improving the landscape of drug delivery options in pharma.
Next-gen chewables
Since gummies have hit the scene, their soft chewable texture have provided a more pleasant patient experience. But the downsides of gummies have prevented wider adoption in pharma.
“Gummies or chewable gels have significant limitations such as poor thermostability that leads to shorter product shelf life and loss of active material throughout the manufacturing process,” Patel explains. “This lack of consistent quality and the cost of scaling up a new manufacturing process are part of why there is a slow adoption of soft chewable pharmaceutical dose forms.”
To overcome these challenges, CURE recently innovated a new line of chewables (pictured above) using its CUREpod technology platform that is capable of encapsulating and stably retaining a wide range of liquid and solid active ingredients. According to the company, CUREpods are made by forming the complexation of polymers stabilized by chemical crosslinking, and can include different layers of API with distinct release profiles.
Link:
https://www.pharmamanufacturing.com/articles/...-delivery/
Product Focus: Advancements in drug delivery
New innovations enhance the patient experience
By Meagan Parrish, Senior Reporter
Apr 28, 2020
CURE 382 1
Oral solid dose may be the backbone of pharma, but recent innovations in drug delivery products are making it easier for patients and pharma companies to utilize alternatives.
“Tablets and gel capsules are compact and convenient for storage and transportation, yet many consumers have difficulty swallowing pills,” explains Bhaumik Patel, director of New Technology for CURE Pharmaceutical. “There are also limitations on the amount of active ingredients that can be delivered due to the size of these dose forms.”
Here’s a look at how innovations for injectables and chewables are improving the landscape of drug delivery options in pharma.
Next-gen chewables
Since gummies have hit the scene, their soft chewable texture have provided a more pleasant patient experience. But the downsides of gummies have prevented wider adoption in pharma.
“Gummies or chewable gels have significant limitations such as poor thermostability that leads to shorter product shelf life and loss of active material throughout the manufacturing process,” Patel explains. “This lack of consistent quality and the cost of scaling up a new manufacturing process are part of why there is a slow adoption of soft chewable pharmaceutical dose forms.”
To overcome these challenges, CURE recently innovated a new line of chewables (pictured above) using its CUREpod technology platform that is capable of encapsulating and stably retaining a wide range of liquid and solid active ingredients. According to the company, CUREpods are made by forming the complexation of polymers stabilized by chemical crosslinking, and can include different layers of API with distinct release profiles.
(0)
(0)Scroll down for more posts ▼